Coronary angiography safe for patients with chronic kidney disease


NEW YORK (Reuters Health), Oct 16 - Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation, and now new research shows that it can be performed in those with advanced chronic kidney disease (CKD) without further impairing kidney function.

Research has shown that outcomes are improved when kidney transplantation is performed before a patient with advanced CKD requires dialysis. However, before transplantation can take place, coronary angiography with possible revascularization is advised for patients over 50 years, those with diabetes, and all candidates with cardiac symptoms or disease, according to the new report.

Concerns have been raised that, because of the risk of contrast-induced nephropathy, coronary angiography may precipitate the need for dialysis, lead author Dr. Nicola Kumar, from Imperial College, London, and colleagues note. Thus, a test that is needed to facilitate preemptive transplantation may at the same time prevent its use.

To investigate the impact of coronary angiography on kidney function, the researchers analyzed data from 482 patients with stage IV/V CKD who were seen from 2004 to 2007. The study focused on 76 of the patients (15.8%) who were transplant candidates and underwent coronary angiography.

The researchers report their findings in the October 15 online issue of the Clinical Journal of the American Society of Nephrology.

The average Modification of Diet in Renal Disease glomerular filtration rate at coronary angiography was 12.46 mL/min, the report indicates. Importantly, this rate did not change significantly from 6 months prior to angiography to 6 months afterward. Cumulative dialysis-free survival was 89.1% at 6 months after angiography.

Flow-limiting coronary disease was identified in 23 of 76 patients (30.3%), the authors note. Twenty-five patients (32.9%) underwent transplantation and in all but three cases, the operation was performed preemptively.

"Coronary angiographic screening did not accelerate the decline in renal function for patients with advanced CKD, which has enabled the facilitation of a safe and prompt preemptive transplantation program," the authors conclude.

Clin J Am Soc Nephrol 2009.

Last Updated: 2009-10-15 17:00:18 -0400 (Reuters Health)

Related Reading

Bicarbonate use cuts risk of contrast nephropathy during PCI, October 13, 2009

High-dose N-acetylcysteine reduces contrast nephropathy, September 14, 2009

Study: Iso-osmolar contrast not safer for kidneys, July 30, 2009

Contrast-induced nephropathy: Much ado about nothing? July 28, 2009

CT angiography unrelated to acute nephropathy, July 27, 2009

Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Page 1 of 1234
Next Page